# Quantification of Parkinson's Disease Patients As a Biomarker for Classification, Prediction and Response to Treatment

> **NCT06586320** · NA · ENROLLING_BY_INVITATION · sponsor: **Stardots AB** · enrollment: 40 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** 150% of their routine home dopaminergic medications dose right in the clinic
- **DEVICE:** Evaluation of mathematical models

## Key facts

- **NCT ID:** NCT06586320
- **Lead sponsor:** Stardots AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-02-06
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06586320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06586320, "Quantification of Parkinson's Disease Patients As a Biomarker for Classification, Prediction and Response to Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06586320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*